BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Li D, Wu JC, Liu ZQ, Zhou HH, Yin JY. Precision dosing of warfarin: open questions and strategies. Pharmacogenomics J 2019;19:219-29. [PMID: 30745565 DOI: 10.1038/s41397-019-0083-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Yan H, Chen Y, Zhu H, Huang W, Cai X, Li D, Lv Y, Si-zhao, Zhou H, Luo F, Zhang W, Li X. The Relationship Among Intestinal Bacteria, Vitamin K and Response of Vitamin K Antagonist: A Review of Evidence and Potential Mechanism. Front Med 2022;9:829304. [DOI: 10.3389/fmed.2022.829304] [Reference Citation Analysis]
2 Quinn AL, Bhat S, Lee JC. Effect of CYP2C9 *11/*11 genotype on initial and long-term warfarin dose requirement and therapeutic response. Pharmacogenomics 2020;21:1271-7. [PMID: 33350885 DOI: 10.2217/pgs-2020-0125] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Amorosi CJ, Chiasson MA, McDonald MG, Wong LH, Sitko KA, Boyle G, Kowalski JP, Rettie AE, Fowler DM, Dunham MJ. Massively parallel characterization of CYP2C9 variant enzyme activity and abundance. Am J Hum Genet 2021;108:1735-51. [PMID: 34314704 DOI: 10.1016/j.ajhg.2021.07.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 12.0] [Reference Citation Analysis]
4 Wang LY, Cui JJ, OuYang QY, Zhan Y, Wang YM, Xu XY, Yu LL, Yin H, Wang Y, Luo CH, Guo CX, Yin JY. Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude. EPMA J 2021;:1-18. [PMID: 34306260 DOI: 10.1007/s13167-021-00247-0] [Reference Citation Analysis]
5 Li D, Zhu H, Luo ZY, Chen Y, Song GB, Zhou XM, Yan H, Zhou HH, Zhang W, Li X. LRP1 polymorphisms associated with warfarin stable dose in Chinese patients: a stepwise conditional analysis. Pharmacogenomics 2020;21:1169-78. [PMID: 33094665 DOI: 10.2217/pgs-2020-0004] [Reference Citation Analysis]
6 Wang Y, Xiao F, Chen Y, Xiao LD, Wang LY, Zhan Y, Xiong XL, Zhou G, Liu R, Ouyang DS, Li Z, McLeod HL, Zhang W, Li Q, Liu ZQ, Zhou HH, Yin JY. Analytics of the clinical implementation of pharmacogenomics testing in 12 758 individuals. Clin Transl Med 2021;11:e586. [PMID: 34841710 DOI: 10.1002/ctm2.586] [Reference Citation Analysis]
7 Shah RR. Genotype‐guided warfarin therapy: Still of only questionable value two decades on. J Clin Pharm Ther 2020;45:547-60. [DOI: 10.1111/jcpt.13127] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 Li D, Luo ZY, Chen Y, Zhu H, Song GB, Zhou XM, Yan H, Zhou HH, Zhang W, Li X. LRP1 and APOA1 Polymorphisms: Impact on Warfarin International Normalized Ratio-Related Phenotypes. J Cardiovasc Pharmacol 2020;76:71-6. [PMID: 32282500 DOI: 10.1097/FJC.0000000000000834] [Reference Citation Analysis]
9 Nguyen VL, Nguyen HD, Cho YS, Kim HS, Han IY, Kim DK, Ahn S, Shin JG. Comparison of multivariate linear regression and a machine learning algorithm developed for prediction of precision warfarin dosing in a Korean population. J Thromb Haemost 2021;19:1676-86. [PMID: 33774911 DOI: 10.1111/jth.15318] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]